<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>小药说药 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-27T08:58:52+08:00</updated>
  <subtitle>姓药的来说药，带你进入最深层次的医药领域，把握医药动态，了解最新前沿！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>国际多中心临床试验的成功要素</title>
    <updated>2020-12-27T06:27:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/2kOeCOSRC6YSL-B4guF20g</id>
    <link href="https://mp.weixin.qq.com/s/2kOeCOSRC6YSL-B4guF20g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“变节”的NK细胞：蜕膜样NK细胞极化</title>
    <updated>2020-12-25T06:26:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/JwJu7ucxLItf3hAgSZGeOg</id>
    <link href="https://mp.weixin.qq.com/s/JwJu7ucxLItf3hAgSZGeOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>癌症研究蓝图：精准医学的关键差距与机遇</title>
    <updated>2020-12-23T06:00:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/vFcrVbyIF4pEE_oksu9ipQ</id>
    <link href="https://mp.weixin.qq.com/s/vFcrVbyIF4pEE_oksu9ipQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤突变负荷作为免疫治疗生物标志物的挑战</title>
    <updated>2020-12-21T06:36:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/zU5pzzbjeXDO5VMwacmYLw</id>
    <link href="https://mp.weixin.qq.com/s/zU5pzzbjeXDO5VMwacmYLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤微环境中的B细胞，助手还是帮凶？</title>
    <updated>2020-12-19T06:45:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/WtEHVe3LDGSJ-zI4p_egJQ</id>
    <link href="https://mp.weixin.qq.com/s/WtEHVe3LDGSJ-zI4p_egJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>鸿运华宁首创治疗肺动脉高压抗体新药完成第一剂量组患者给药</title>
    <updated>2020-12-18T11:47:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/6yww8yoxZTP77Q_AyXgs4Q</id>
    <link href="https://mp.weixin.qq.com/s/6yww8yoxZTP77Q_AyXgs4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤及其微环境中的内质网应激信号</title>
    <updated>2020-12-17T06:15:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/-pbdHCih8hSn7fhKFp2Qtw</id>
    <link href="https://mp.weixin.qq.com/s/-pbdHCih8hSn7fhKFp2Qtw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>航空港区首个国家一类创新药大规模生产基地鸿运华宁郑州生产基地项目启动</title>
    <updated>2020-12-16T08:06:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/eKNLLupB4FqtPC1N-2BZpA</id>
    <link href="https://mp.weixin.qq.com/s/eKNLLupB4FqtPC1N-2BZpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点2020上市的抗体新药-（9）naxitamab</title>
    <updated>2020-12-15T06:04:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/QjLauRRGKeZK4FhoFoQT2g</id>
    <link href="https://mp.weixin.qq.com/s/QjLauRRGKeZK4FhoFoQT2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>资本与技术共舞，ADC迎来盛世华年</title>
    <updated>2020-12-13T06:15:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/0XaLtRiSGV9lzAD1pJGORA</id>
    <link href="https://mp.weixin.qq.com/s/0XaLtRiSGV9lzAD1pJGORA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>